Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission
Authors:
- 1 September 2015
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 136, 107-116
Abstract
No abstract availableKeywords
Funding Information
- University Grants Commission
- Birla Institute of Technology and Science, Pilani
This publication has 109 references indexed in Scilit:
- Association of Anxiety and Depression With All‐Cause Mortality in Individuals With Coronary Heart DiseaseJournal of the American Heart Association, 2013
- A Neural Circuitry Linking Insulin Resistance to Depressed MoodPsychosomatic Medicine, 2012
- Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3β/β-catenin signalingMolecular Psychiatry, 2011
- Randomized, Placebo-Controlled Trials of Antidepressants for Acute Major Depression: Thirty-Year Meta-Analytic ReviewNeuropsychopharmacology, 2011
- Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fatClinical Endocrinology, 2011
- Oxidative stress: A potential recipe for anxiety, hypertension and insulin resistanceBrain Research, 2010
- NOX activity in brain aging: Exacerbation by high fat dietFree Radical Biology and Medicine, 2010
- Obesity alters circadian expressions of molecular clock genes in the brainstemBrain Research, 2009
- Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in miceEuropean Journal of Pharmacology, 2008
- Association Between Obesity and Psychiatric Disorders in the US Adult PopulationArchives of General Psychiatry, 2006